Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 16
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    McLaren, Donald G. Sperling, Reisa A. and Atri, Alireza 2014. Flexible modulation of network connectivity related to cognition in Alzheimer's disease. NeuroImage, Vol. 100, p. 544.

    O'Caoimh, R. Gao, Y. Gallagher, P. F. Eustace, J. McGlade, C. and Molloy, D. W. 2013. Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?. Age and Ageing, Vol. 42, Issue. 3, p. 324.

    McLaren, Donald G. Sreenivasan, Aishwarya Diamond, Eli L. Mitchell, Meghan B. Van Dijk, Koene R.A. DeLuca, Amy N. O’Brien, Jacqueline L. Rentz, Dorene M. Sperling, Reisa A. and Atri, Alireza 2012. Tracking Cognitive Change over 24 Weeks with Longitudinal Functional Magnetic Resonance Imaging in Alzheimer’s Disease. Neurodegenerative Diseases, Vol. 9, Issue. 4, p. 176.

    Peña-Casanova, Jordi Sánchez-Benavides, Gonzalo de Sola, Susana Manero-Borrás, Rosa Maria and Casals-Coll, Marta 2012. Neuropsychology of Alzheimer's Disease. Archives of Medical Research, Vol. 43, Issue. 8, p. 686.

    Mcintyre, John A. Wagenknecht, Dawn R. and Ramsey, Curtis J. 2009. Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls. Autoimmunity, Vol. 42, Issue. 8, p. 646.

    Oda, Haruhiko Yamamoto, Yasuji and Maeda, Kiyoshi 2009. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, Vol. 24, Issue. 2, p. 125.

    Qin, Zhaohui Zhang, Liyan Sun, Fei Fang, Xianghua Meng, Cheryl Tanner, Caroline and Chan, Piu 2009. Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism & Related Disorders, Vol. 15, Issue. 10, p. 767.

    Qin, Zhaohui Zhang, Liyan Sun, Fei Liu, Hongjun Fang, Xianghua and Chan, Piu 2009. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: Results from Chinese l-dopa exposed cohort. Clinical Neurology and Neurosurgery, Vol. 111, Issue. 9, p. 733.

    Dalla Barba, Gianfranco Traykov, Latchezar and Baudic, Sophie 2008. Dementias.

    Peskind, Elaine R. Potkin, Steven G. Pomara, Nunzio Ott, Brian R. Graham, Stephen M. Olin, Jason T. and McDonald, Scott 2006. Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial. The American Journal of Geriatric Psychiatry, Vol. 14, Issue. 8, p. 704.

    Streiner, David L. and Norman, Geoffrey R. 2006. “Precision” and “Accuracy”: Two Terms That Are Neither. Journal of Clinical Epidemiology, Vol. 59, Issue. 4, p. 327.

    2006. The Dementias.

    Snellgrove, Carol A and Hecker, Jane R 2005. Brief checklist for non-cognitive symptoms of dementia. Australasian Journal on Ageing, Vol. 24, Issue. 2, p. 88.

    Matthews, Brandy Siemers, Eric R. and Mozley, P. David 2003. Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease. The American Journal of Geriatric Psychiatry, Vol. 11, Issue. 2, p. 146.

    Youn, J. C. Lee, D. Y. Kim, K. W. Lee, J. H. Jhoo, J. H. Lee, K. U. Ha, J. and Woo, J. I. 2002. Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K). International Journal of Geriatric Psychiatry, Vol. 17, Issue. 9, p. 797.

    Boller, F. and Barba, G. Dalla 2001. Neuropsychological tests in Alzheimer’s disease. Aging Clinical and Experimental Research, Vol. 13, Issue. 3, p. 210.


Alzheimer's Disease Assessment Scale–Cognitive in Clinical Practice

  • Jordi Peña-Casanova (a1) (a2)
  • DOI:
  • Published online: 01 December 1997

The goal of this article is (a) to review a series of measurement standards for group and individual-patient applications of cognitive tests for Alzheimer's disease (AD); and (b) to review the literature and to use specific data from the NORMACODEM (a project of standardization of cognitive and functional tools for AD) to evaluate the measurement standards of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog). Seven measurement standards for group and individual patient use were evaluated: practicality, extent of measurement, depth of measurement, cross-sectional precision, longitudinal precision, validity, and standardization. The results indicated that ADAS-Cog meets practicality standards, that the scoring method is not difficult, but training is needed to administer the test. In comparison with other rating scales, the ADAS-Cog is regarded as more comprehensive, although it is not a substitute for an extensive neuropsychological test. The ADAS-Cog is not a tool that is suitable for primary care physicians, although it is a valuable screening test that has utility in both early detection (diagnosis) and staging of AD, and is useful in the severity range of Global Dementia stages 1 to 6. Interrater reliability coefficients for the ADAS-Cog satisfy recommended standards, and the test shows good internal consistency and reproducibility. Age and education are associated with the ADAS-Cog score. There is, however, a lack of standardization, which restricts the comparability of study results, and test materials remain unpublished.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *